Hove Anders D

CIK 000136561812 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001365618

Recent Transactions

50 trades

Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2024-01-30+6,000→ 6,000 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2022-12-15+6,000→ 6,000 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2021-01-12+12,000→ 12,000 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2018-03-01+8,000→ 8,000 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2017-02-16+10,000→ 10,000 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-06-24−15,000→ 0 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-06-24−30,000→ 0 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-06-24−12,500→ 0 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Common Stock
2016-06-24$99.25/sh−33,886→ 0 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-06-24−15,000→ 0 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-06-24−4,096→ 0 total
Disposition to Issuer
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-06-24−15,000→ 0 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-05-16$98.93/sh−72,385→ 0 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-05-16$100.60/sh−81,631→ 272,250 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-05-16$99.41/sh−199,865→ 72,385 total
Conversion
Anacor Pharmaceuticals, Inc.
2.00% Convertible Senior Notes due 2021
2016-04-14
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-14$31.05/sh+257,647→ 353,881 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-08$70.05/sh−3,868→ 96,634 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-08$71.40/sh−400→ 96,234 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-07$73.29/sh−2,272→ 107,522 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-07$70.33/sh−102,760→ 222,775 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-07$74.13/sh−200→ 107,322 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-07$71.44/sh−99,981→ 122,794 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-07$75.57/sh−6,820→ 100,502 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2016-04-07$72.15/sh−13,000→ 109,794 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2015-12-15$111.25/sh−900,000→ 325,535 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2015-12-11$117.36/sh−40,000→ 33,886 total
Other
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-10+73,092→ 73,886 total
Other
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-10−372,982→ 1,225,535 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-10$103.60/sh−100,295→ 1,598,517 total
Other
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-03+372,982→ 1,598,517 total
Other
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-03−1,500,000→ 1,225,535 total
Other
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-03−1,399,705→ 1,325,830 total
Other
Anacor Pharmaceuticals, Inc.
Common Stock
2015-11-03+372,982→ 1,698,812 total
Purchase
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06$11.00/sh+450,000→ 2,021,917 total
Other
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06$8.60/sh+46,665→ 2,068,582 total
Conversion
PDS Biotechnology Corp$PDSB
Series C-2 Convertible Preferred Stock
2015-10-06−2,150,538→ 0 total
Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06+1,571,917→ 1,571,917 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-06-09+4,096→ 4,096 total
Award
Anacor Pharmaceuticals, Inc.
Common Stock
2015-06-09+794→ 794 total
Award
Anacor Pharmaceuticals, Inc.
2.00% Convertible Senior Notes due 2021
2014-10-16$8000000.00/sh
Award
Anacor Pharmaceuticals, Inc.
2.00% Convertible Debentures due 2021
2014-10-16$8000000.00/sh
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-26$25.00/sh−20,000→ 2,725,535 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-19$24.87/sh−738,500→ 2,745,535 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-18$24.87/sh−1,500→ 3,484,035 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-16$24.99/sh−75,000→ 3,485,535 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-12$24.98/sh−15,000→ 3,560,535 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2013-11-15$14.06/sh−150,000→ 3,575,535 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-06-06+15,000→ 15,000 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2012-09-20$6.30/sh−19,273→ 3,725,535 total

Companies

Recent Filings

Address

C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508

NEW YORK, NY, 10112

View on SEC.gov